Theoretical investigation on nevirapine and HIV-1 reverse transcriptase binding site interaction, based on ONIOM method

被引:68
作者
Kuno, M
Hannongbua, S [1 ]
Morokuma, K
机构
[1] Kasetsart Univ, Fac Sci, Dept Chem, Bangkok 10900, Thailand
[2] Emory Univ, Dept Chem, Atlanta, GA 30323 USA
[3] Emory Univ, Cherry L Emerson Ctr Sci Computat, Atlanta, GA 30323 USA
关键词
D O I
10.1016/j.cplett.2003.09.030
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
The ONIOM method was applied to the interaction of nevirapine with the HIV-1 reverse transcriptase binding site. The isolated complex of pyridine (part of nevirapine) and methyl phenol (part of Tyr181) was found at the MP2/631+G(d) level to have stacking interaction with 8.8 kcal/mol binding energy. Optimization of nevirapine and Tyr181 geometry in the pocket of 16 amino acid residues at the ONIOM3(MP2/6-31G(d):HF/3-21G:PM3) level gave the complex structure with weak hydrogen bonding but without stacking interaction. The binding energy of 8.9 kcal/mol comes almost entirely from the interaction of nevirapine with amino acid residues other than Tyr181. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:456 / 463
页数:8
相关论文
共 24 条
[1]   The Y181C mutant of HIV-1 reverse transcriptase resistant to nonnucleoside reverse transcriptase inhibitors alters the size distribution of RNase H cleavages [J].
Archer, RH ;
Wisniewski, M ;
Bambara, RA ;
Demeter, LM .
BIOCHEMISTRY, 2001, 40 (13) :4087-4095
[2]   DENSITY-FUNCTIONAL THERMOCHEMISTRY .3. THE ROLE OF EXACT EXCHANGE [J].
BECKE, AD .
JOURNAL OF CHEMICAL PHYSICS, 1993, 98 (07) :5648-5652
[3]   DENSITY-FUNCTIONAL EXCHANGE-ENERGY APPROXIMATION WITH CORRECT ASYMPTOTIC-BEHAVIOR [J].
BECKE, AD .
PHYSICAL REVIEW A, 1988, 38 (06) :3098-3100
[4]  
CARDOZO MG, 1993, J MOL GRAPHICS, V11, P272
[5]   A new ONIOM implementation in Gaussian98.: Part I.: The calculation of energies, gradients, vibrational frequencies and electric field derivatives [J].
Dapprich, S ;
Komáromi, I ;
Byun, KS ;
Morokuma, K ;
Frisch, MJ .
JOURNAL OF MOLECULAR STRUCTURE-THEOCHEM, 1999, 461 :1-21
[6]   HIV RESISTANCE TO REVERSE-TRANSCRIPTASE INHIBITORS [J].
DECLERCQ, E .
BIOCHEMICAL PHARMACOLOGY, 1994, 47 (02) :155-169
[7]  
DeClercq E, 1996, MED RES REV, V16, P125, DOI 10.1002/(SICI)1098-1128(199603)16:2<125::AID-MED1>3.0.CO
[8]  
2-2
[9]  
FRISCH MJ, 1998, GAUSSIAN98
[10]   Conformational analysis of nevirapine, a non-nucleoside HIV-1 reverse transcriptase inhibitor, based on quantum mechanical calculations [J].
Hannongbua, S ;
Prasithichokekul, S ;
Pungpo, P .
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2001, 15 (11) :997-1004